BIOCON
Back to All Ratios
|
BIOCON Last 5 Year EV/EBIT History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/EBIT(x) | 19.61 | 18.07 | 30.50 | 41.23 | 45.64 |
What is the latest EV/EBIT ratio of BIOCON ?
Year | EV/EBIT |
---|---|
Mar2025 | 19.61 |
Mar2024 | 18.07 |
Mar2023 | 30.50 |
Mar2022 | 41.23 |
Mar2021 | 45.64 |
How is EV/EBIT of BIOCON Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2025 | 19.61 | 8.52 | |
Mar2024 | 18.07 | -40.75 | |
Mar2023 | 30.5 | -26.02 | |
Mar2022 | 41.23 | -9.66 | |
Mar2021 | 45.64 | - |
Other Financial Ratios of BIOCON
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹48,693.5 Cr | 6.5% | -8.2% | 9.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | 6.5% |
-8.2% |
9.7% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses